Login HereHelp
|
Oral Cancer This year, 8,000 people will die from oral cancer and over 30,000 new cases will be diagnosed in the United States. The OralCDX brush biopsy is a valuable tool in the early detection of oral cancer/precancerous cells and represents a major breakthrough in the fight against oral cancer. The procedure is indicated to evaluate unexplained tiny white and red lesions -- and the software used to analyse the samples can spot a precancerous/cancerous cell even if it is partially obscured by other cells. The OralCDx brush biopsy is covered under oral sugery in all Delta Dental of Illinois' benefit programs that include oral surgery coverage. For more information, click here. |